Walking Fish Therapeutics
Jennifer Sechrist is a seasoned finance professional with extensive experience in financial planning and analysis, currently serving as Vice President of Finance at Walking Fish Therapeutics, Inc. since September 2022. Jennifer has held significant roles such as Executive Director of Financial Planning & Analysis at Harpoon Therapeutics and Senior Director of Financial Planning & Analysis at Zosano Pharma, where responsibilities included developing budget versus actual reports and monthly forecasting processes. Previous positions include Director of Finance at Knight Ridder, Senior Manager at Ernst & Young, and various roles in financial management with a strong emphasis on R&D, budgeting, and stakeholder communication. Jennifer holds a BA in Finance from the University of Illinois Urbana-Champaign.
This person is not in any teams
This person is not in any offices
Walking Fish Therapeutics
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding of B cell biology.